"It really hurts to leave Hanwha, but I thought it was right to play baseball considering my family and my child, so I asked ...

SLT‑MOBITEL, the National ICT Solutions Provider, reaffirmed leadership in corporate accountability and transparency, winning ...

ViaLase announced the first patient has been treated in its US-based Investigational Device Exemption (IDE) clinical trial ...

Stead added that while SLT is now the first treatment that is offered to patients, a range of topical medications in the form ...

ViaLase, Inc., a clinical-stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that the first patient has been treated in its U.S.

ALISO VIEJO, Calif.--(BUSINESS WIRE)--#POAG--ViaLase, Inc., a clinical-stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that the first ...

The SLT Group has reported a robust financial performance for the third quarter and nine months ended September 30, 2025, continuing an upward trajectory with substantial improvements in profitability ...

CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops, long-term follow-up from a large randomized trial showed. After 6 years ...

Glaucoma specialists may now be opting for selective laser trabeculoplasty instead of topical drops for treatment-naïve ocular hypertension and open-angle glaucoma. A majority of American glaucoma ...